Economical and Organizational Impact of Adopting Different in Situ Hybridization Technologies to Assess HER2 Gene Amplification in Breast Cancer

Vincenzo Arena, D Paolini, R Rossoni, D Guardione

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

Human epidermal growth factor receptor 2 (HER2) status identification is established by immunohistochemistry and in situ hybridisation (ISH). Silver in situ hybridisation (SISH) is an alternative technique to the fluorescence in situ hybridization (FISH). Both methods are recommended by American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) 2013 guidelines. The primary aim of this analysis is to evaluate the economical and organizational impact by adopting FISH or SISH test for HER2 testing.
Lingua originaleEnglish
pagine (da-a)361-2-362
RivistaValue in Health
Volume18
DOI
Stato di pubblicazionePubblicato - 2015

Keywords

  • HER2,Economical

Fingerprint

Entra nei temi di ricerca di 'Economical and Organizational Impact of Adopting Different in Situ Hybridization Technologies to Assess HER2 Gene Amplification in Breast Cancer'. Insieme formano una fingerprint unica.

Cita questo